Innovative Molecules
Business Services · Germany · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Dachauer St 65, Munich, Bavaria, 80335, ...Phone Number
+49 1759440448Website
www.innovativemolecules.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Innovative Molecules
Innovative Molecules is focused on developing next-generation treatments for diseases induced by herpes simplex. The company specializes in creating novel therapies, such as IM-250, a selective HSV-helicase primase inhibitor designed to block DNA unwinding. Their dedicated team of clinical and medical experts aims to improve the lives of patients suffering from herpes-mediated diseases. The company is actively advancing its pipeline and has recently announced progress in clinical trials and partnerships for its innovative treatments.Explore more
Popular SearchesInnovative MoleculesInnovative Molecules GmbHSIC Code 87,873NAICS Code 54,541Show moreInnovative Molecules Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Innovative Molecules your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Innovative Molecules has new funding data
Check if Innovative Molecules has recently received funding, and reach out quickly before it becomes old news!
Click to see if Innovative Molecules had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Innovative Molecules, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Innovative Molecules is spiking on competitors!
Earning: See what the market has to say on Innovative Molecules recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Innovative Molecules
Product Launch: Get notified when Innovative Molecules launches new products
Recommended Actions
Find VP level buyers at Innovative Molecules
Find more new buyers
Company Profile Activity
Activity Insights
Innovative Molecules is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Innovative Molecules is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Innovative Molecules.
Innovative Molecules financials insights
Gather financial insights about Innovative Molecules, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$24.4M
Innovative Molecules Tech Stack
A closer look at the technologies used by Innovative Molecules
See more technologies
Innovative Molecules News & Media
Innovative Molecules Announces First Patient Dosed in Phase 2a Trial of Adibelivir (IM-250), Advancing Company into Late-Stage Clinical Development
MUNICH, June 25, 2026 /PRNewswire/ -- Innovative Molecules GmbH, a late-stage clinical biotechnology company focused on the development of differentiated antiviral therapies, today announced that the first patient has been dosed in its Phase 2a clinical trial evaluating adibelivir...Innovative Molecules Expands Virology Pipeline with Novel EBV Antiviral Program
MUNICH, June 16, 2026 /PRNewswire/ -- Innovative Molecules GmbH ("IM"), a clinical-stage biopharmaceutical company focused on herpesvirus-mediated diseases, today announced the advancement of its virology pipeline with the addition of a novel Epstein-Barr Virus (EBV) antiviral program....Innovative Molecules Announces Completion of Phase 1 Program and Advancement to Phase 2 for Oral Adibelivir
MUNICH, Jan. 29, 2026 /PRNewswire/ -- Innovative Molecules GmbH, a German clinical stage biotech company focused on development of novel agents in the field of herpes-mediated diseases, today announced the successful completion of its Phase 1 clinical development program and the...Alfasigma Secures Exclusive Rights from Innovative Molecules to Parenteral Adibelivir for Treatment of HSV Encephalitis, an Ultra-Rare Disease
BOLOGNA, Italy and MUNICH, Jan. 14, 2026 /PRNewswire/ -- Alfasigma S.p.A. ("Alfasigma"), a global pharmaceutical company, and Innovative Molecules GmbH ("Innovative Molecules"), a clinical-stage biotechnology company, today announced a strategic partnership whereby Alfasigma will invest...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Innovative Molecules
Sign Up For FreeTo access detailed company insights
Innovative Molecules is focused on developing next-generation treatments for diseases induced by herpes simplex. The company specializes in creating novel therapies, such as IM-250, a selective HSV-helicase primase inhibitor designed to block DNA unwinding. Their dedicated team of clinical and medical experts aims to improve the lives of patients s... Read More
